Babak Baban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Babak Baban has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Jun Yao Liu
3 shared publicationsMahmood S. Mozaffari
3 shared publications- David Pashley
Department of Oral Biology & Maxillofacial Pathology, School of Dentistry, Medical College of Georgia, Augusta, GA 30912-1129, USA
1 shared publication - Franklin Tay
Dental College of Georgia, Augusta University, Augusta, GA, USA
1 shared publication - Jun Yao Liu
Department of Oral Biology, Georgia Regents University, Building: CL 2140, 1120 15th Street, Augusta, GA 30912 USA
1 shared publication
Latest Publications
- 1 April 2013
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 94 (2) , 343-351
Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1
- 1 April 2013
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 94 (2) , 343-351
Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1
- 1 January 2013
- Published by Wolters Kluwer Health in Hypertension
- Vol. 61 (1) , 95-104
Pressure Overload Regulates Expression of Cytokines, γH2AX, and Growth Arrest- and DNA-Damage Inducible Protein 153 via Glycogen Synthase Kinase-3β in Ischemic-Reperfused Hearts
The growth arrest- and DNA-damage inducible protein 153 (GADD153) regulates both apoptosis and inflammatory response. Importantly, glycogen synthase kinase-3β (GSK-3β) may provide a mechanistic link for cellular expression of GADD153, inflammatory response, and cell death. We previously showed that pressure overload exacerbates myocardial ischemia reperfusion injury associated with significant reduction in phosphorylated (inactive) GSK-3β. This raises the possibility that pressure overload, through a GSK-3β-dependent mechanism, increases GADD153 expression, thereby upregulating inflammatory cytokine production and contributing to worsening of myocardial ischemia reperfusion injury. Accordingly, Langendorff-perfused rat hearts were subjected to global ischemia reperfusion protocol in the absence or presence of the GSK-3β inhibitor, lithium chloride (1 mmol/L), with perfusion pressure set at 80 or 160 cmH 2 O; normoxic hearts served as controls. Compared with normoxia, an ischemia reperfusion insult increased expressions of proinflammatory cytokines, γH2AX, and GADD153 in association with increased cell death. In the ischemic-reperfused hearts, pressure overload did the following: (1) reduced interleukin-10 but increased interleukin-17 (cardiomyocytes), without affecting interleukin-23; (2) increased expressions of γH2AX and GADD153; (3) decreased 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) aggregates but increased JC-1 monomers (suggestive of reduced mitochondrial membrane potential, ψ m ); and (4) increased annexin V immunostaining as well as apoptotic and necrotic cell death. Treatment with lithium chloride caused a robust increase in interleukin-10, preserved ψ m , and markedly decreased all other parameters with the effect being most prominent for hearts perfused at the high pressure. In conclusion, pressure overload, via a GSK-3β-dependent mechanism, exacerbates cell death in the isolated ischemic-reperfused heart involving regulation of inflammatory response, DNA injury, and GADD153 expression.
- 1 January 2013
- Published by Wolters Kluwer Health in Hypertension
- Vol. 61 (1) , 95-104
Pressure Overload Regulates Expression of Cytokines, γH2AX, and Growth Arrest- and DNA-Damage Inducible Protein 153 via Glycogen Synthase Kinase-3β in Ischemic-Reperfused Hearts
The growth arrest- and DNA-damage inducible protein 153 (GADD153) regulates both apoptosis and inflammatory response. Importantly, glycogen synthase kinase-3β (GSK-3β) may provide a mechanistic link for cellular expression of GADD153, inflammatory response, and cell death. We previously showed that pressure overload exacerbates myocardial ischemia reperfusion injury associated with significant reduction in phosphorylated (inactive) GSK-3β. This raises the possibility that pressure overload, through a GSK-3β-dependent mechanism, increases GADD153 expression, thereby upregulating inflammatory cytokine production and contributing to worsening of myocardial ischemia reperfusion injury. Accordingly, Langendorff-perfused rat hearts were subjected to global ischemia reperfusion protocol in the absence or presence of the GSK-3β inhibitor, lithium chloride (1 mmol/L), with perfusion pressure set at 80 or 160 cmH 2 O; normoxic hearts served as controls. Compared with normoxia, an ischemia reperfusion insult increased expressions of proinflammatory cytokines, γH2AX, and GADD153 in association with increased cell death. In the ischemic-reperfused hearts, pressure overload did the following: (1) reduced interleukin-10 but increased interleukin-17 (cardiomyocytes), without affecting interleukin-23; (2) increased expressions of γH2AX and GADD153; (3) decreased 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) aggregates but increased JC-1 monomers (suggestive of reduced mitochondrial membrane potential, ψ m ); and (4) increased annexin V immunostaining as well as apoptotic and necrotic cell death. Treatment with lithium chloride caused a robust increase in interleukin-10, preserved ψ m , and markedly decreased all other parameters with the effect being most prominent for hearts perfused at the high pressure. In conclusion, pressure overload, via a GSK-3β-dependent mechanism, exacerbates cell death in the isolated ischemic-reperfused heart involving regulation of inflammatory response, DNA injury, and GADD153 expression.
- 1 December 2012
- Vol. 25 (6) , 327-31
Use of a new, simple, laboratory method for screening the antimicrobial and antiviral properties of hand sanitizers.
To develop a simple, laboratory method for screening the antimicrobial/antiviral activity of hand sanitizers, to replace the more time consuming use of human volunteers. A Rapid Agar Plate Assay (RAPA) was developed that uses sterile agar plates to simulate skin surfaces. After treating the agar plates with putative hand sanitizers, the plates were inoculated with gram-positive S. aureus or gram-negative E. coli. Untreated agar plates served as controls. After incubation for 48 hours, the bacteria were recovered and stained with fluorescent dyes. The number of live/dead bacteria was quantitated by flow cytometry. For anti-viral activity, mammalian cell lines were grown to confluency and infected with noroviruses (murine norovirus or feline calicivirus), and the number of dead cells was quantitated as the log10 of number of cells killed. A liquid hand soap without any antibacterial activity (LHS) was used as the control. A popular ethanol-based hand sanitizer (GHS) was compared to a new quaternary ammonium-containing bactericidal hand cream (ABC). The liquid soap was not effective against either gram-positive or gram-negative bacteria, or viruses. Both GHS and ABC were very effective against S. aureus, but much less so against E. coli. Both GHS and ABC were even more effective against the two noroviruses that cause gastrointestinal diseases, than they were against gram-positive bacteria. These results support the use of RAPA as an effective laboratory screening test to evaluate the antibacterial/antiviral activity of hand sanitizers or other antimicrobial products.
- 1 December 2012
- Vol. 25 (6) , 327-31
Use of a new, simple, laboratory method for screening the antimicrobial and antiviral properties of hand sanitizers.
To develop a simple, laboratory method for screening the antimicrobial/antiviral activity of hand sanitizers, to replace the more time consuming use of human volunteers. A Rapid Agar Plate Assay (RAPA) was developed that uses sterile agar plates to simulate skin surfaces. After treating the agar plates with putative hand sanitizers, the plates were inoculated with gram-positive S. aureus or gram-negative E. coli. Untreated agar plates served as controls. After incubation for 48 hours, the bacteria were recovered and stained with fluorescent dyes. The number of live/dead bacteria was quantitated by flow cytometry. For anti-viral activity, mammalian cell lines were grown to confluency and infected with noroviruses (murine norovirus or feline calicivirus), and the number of dead cells was quantitated as the log10 of number of cells killed. A liquid hand soap without any antibacterial activity (LHS) was used as the control. A popular ethanol-based hand sanitizer (GHS) was compared to a new quaternary ammonium-containing bactericidal hand cream (ABC). The liquid soap was not effective against either gram-positive or gram-negative bacteria, or viruses. Both GHS and ABC were very effective against S. aureus, but much less so against E. coli. Both GHS and ABC were even more effective against the two noroviruses that cause gastrointestinal diseases, than they were against gram-positive bacteria. These results support the use of RAPA as an effective laboratory screening test to evaluate the antibacterial/antiviral activity of hand sanitizers or other antimicrobial products.
- 1 December 2012
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 303 (11) , R1136-R1146
Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells
The aryl hydrocarbon receptor (AHR) has emerged as a major modulator of inflammatory processes. We tested the hypothesis that AHR activation protects the ischemic-reperfused kidney in association with the suppression of the inflammatory response. Accordingly, male mice were treated with the nondioxin AHR agonist, leflunomide (40 mg/kg ip); vehicle-treated animals served as controls. Thereafter, the right kidney was subjected to an ischemia (45 min)-reperfusion (4 h) insult, while the left kidney served as a sham control. Renal cells prepared from ischemic-reperfused kidneys of leflunomide-treated mice displayed preservation of mitochondrial membrane potential (Ψm) and decreased apoptosis and necrosis compared with vehicle-treated ischemic-reperfused kidneys. Leflunomide treatment increased regulatory T cells (Tregs; forkhead box P3+) and IL-10-positive cells but reduced IL-17- and IL-23-expressing cells in both the peripheral blood and kidney cells, indicative of down-regulation of inflammatory responses. Leflunomide treatment also increased mobilization of stems cells subsets (i.e., mesenchymal and hematopoietic stem cells and endothelial progenitor cells) in the peripheral blood and promoted their recruitment into the ischemic-reperfused kidney. Collectively, the results indicate that AHR stimulation may represent a novel renoprotective mechanism likely involving mobilization and recruitment of Tregs and stem cells into the damaged kidney.
- 1 December 2012
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 303 (11) , R1136-R1146
Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: role of Tregs and stem cells
The aryl hydrocarbon receptor (AHR) has emerged as a major modulator of inflammatory processes. We tested the hypothesis that AHR activation protects the ischemic-reperfused kidney in association with the suppression of the inflammatory response. Accordingly, male mice were treated with the nondioxin AHR agonist, leflunomide (40 mg/kg ip); vehicle-treated animals served as controls. Thereafter, the right kidney was subjected to an ischemia (45 min)-reperfusion (4 h) insult, while the left kidney served as a sham control. Renal cells prepared from ischemic-reperfused kidneys of leflunomide-treated mice displayed preservation of mitochondrial membrane potential (Ψm) and decreased apoptosis and necrosis compared with vehicle-treated ischemic-reperfused kidneys. Leflunomide treatment increased regulatory T cells (Tregs; forkhead box P3+) and IL-10-positive cells but reduced IL-17- and IL-23-expressing cells in both the peripheral blood and kidney cells, indicative of down-regulation of inflammatory responses. Leflunomide treatment also increased mobilization of stems cells subsets (i.e., mesenchymal and hematopoietic stem cells and endothelial progenitor cells) in the peripheral blood and promoted their recruitment into the ischemic-reperfused kidney. Collectively, the results indicate that AHR stimulation may represent a novel renoprotective mechanism likely involving mobilization and recruitment of Tregs and stem cells into the damaged kidney.